Kinnate Biopharma Inc.
Inhibitors of fibroblast growth factor receptor kinases
Last updated:
Abstract:
Provided herein are heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
Status:
Grant
Type:
Utility
Filling date:
4 Jun 2021
Issue date:
31 May 2022